Bipartisan FDA reform bill could pass in 1996, Kennedy staffer says.
This article was originally published in The Tan Sheet
Executive Summary
KENNEDY's "FOUR PILLARS" OF FDA REFORM INCLUDE IMPROVED MANAGEMENT and IND/NDA review process changes, a staffer to Sen. Edward Kennedy (D-Mass.) told a Progress & Freedom Foundation conference on FDA reform Feb. 7 in Washington, D.C. David Nexon, health office staff director for the Senate Labor and Human Resources Committee's ranking Democrat, defined "better management" as "improved consistency, improved fairness in dealing with companies and improved predictability."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning